Yamamoto M, Nagao M, Matsumura Y, Matsushima A, Ito Y, Takakura S, et al. Interspecies dissemination of a novel class 1 integron carrying bla
IMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother. 2011;66:2480–3.
Article
CAS
PubMed
Google Scholar
Villalon P, Valdezate S, Medina-Pascual MJ, Carrasco G, Vindel A, Saez-Nieto JA. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysingoxacillinase and metallo-beta-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother. 2013;68:550–3.
Article
CAS
PubMed
Google Scholar
Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86:260–6.
Article
CAS
PubMed
Google Scholar
Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49:3198–202.
Article
CAS
PubMed
PubMed Central
Google Scholar
Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis Off Publ Infect Dis Soc Am. 2003;37:214–20.
Article
CAS
Google Scholar
Amudhan MS, Sekar U, Kamalanathan A, Balaraman S. bla
IMP and bla
VIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infect Develop Ctries. 2012;6:757–62.
Article
CAS
Google Scholar
Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol. 2005;8:518–24.
Article
CAS
PubMed
Google Scholar
Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, et al. OXA- and GES-type beta-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20:410–5.
Article
CAS
PubMed
Google Scholar
Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis. 2006;12:981–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kusradze I, Diene SM, Goderdzishvili M, Rolain JM. Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia. Int J Antimicrob Agents. 2011;38:164–8.
Article
CAS
PubMed
Google Scholar
Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:1087–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abbas M, Cherkaoui A, Fankhauser C, Schrenzel J, Harbarth S. Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland. Rev Med Suisse. 2012;8:882–4.
CAS
PubMed
Google Scholar
Sarhaddi N, Soleimanpour S, Farsiani H, Mosavat A, Dolatabadi S, Salimizand H, et al. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran. J Glob Antimicrob Resist. 2016;8:60–6.
Article
PubMed
Google Scholar
Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50:4114–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Misbah S, Hassan H, Yusof MY, Hanifah YS, Abu-Bakar S. Genomic species identification of Acinetobacter of clinical isolates by 16S rDNA sequencing. Singapore. Med J. 2005;46:461–4.
CAS
Google Scholar
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27:351–3.
Article
CAS
PubMed
Google Scholar
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, document M100-24. Wayne: Clinical and Laboratory Standards Institute; 2014.
Google Scholar
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.
Article
CAS
PubMed
Google Scholar
Liu Y, Liu X. Detection of AmpC β-lactamases in Acinetobacter baumannii in the Xuzhou region and analysis of drug resistance. Exp Ther Med. 2015;10:933–6.
CAS
PubMed
PubMed Central
Google Scholar
Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59:321–2.
Article
CAS
PubMed
Google Scholar
Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119–23.
Article
CAS
PubMed
Google Scholar
Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. Prevalence of IS (Aba1) in epidemiologically unrelated Acinetobacter baumannii clinical isolates. FEMS Microbiol Lett. 2007;274:63–6.
Article
CAS
PubMed
Google Scholar
Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40:3798–801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vila J, Marcos MA, Jiminez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol. 1996;44:482–9.
Article
CAS
PubMed
Google Scholar
Grundmann HJ, Towner KJ, Dijkshoorn L, Gerner-Smidt P, Maher M, Seifert H, et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol. 1997;35:3071–7.
CAS
PubMed
PubMed Central
Google Scholar
Shrestha S, Tadab T, Miyoshi-Akiyamac T, Oharad H, Shimadab K, Satoue K, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46:526–31.
Article
CAS
PubMed
Google Scholar
Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother. 2010;54:4168–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cherkaoui A, Emonet S, Renzi G, Schrenzel J. Characteristics of multidrug-resistant Acinetobacter baumannii strains isolated in Geneva during colonization or infection. Ann Clin Microbiol Antimicrob. 2015;11:14–42.
Google Scholar
Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57:2121–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zander E, Bonnin RA, Seifert H, Higgins PG. Characterization of bla
OXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii. Antimicrob Agents Chemother. 2014;58:2704–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Viana GF, Zago MC, Moreira RR, Zarpellon MN, Menegucci TC, Cardoso CL, et al. ISAba1/bla
OXA-23: A serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains. Am J Infect Control. 2016;44:593–5.
Article
CAS
PubMed
Google Scholar
Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, Anais L, et al. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Eurosurveillance. 2013;18. doi:10.2807/1560-7917.ES2013.18.31.20547
Mathlouthi N, El Salabi AA, Ben Jomàa-Jemili M, Bakour S, Al-Bayssari C, Zorgani AA, et al. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals. Int J Antimicrob Agents. 2016;48:46–50.
Article
CAS
PubMed
Google Scholar
Toleman MA, Spencer J, Jones L, Walsh TR. bla
NDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:2773–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramoul A, Loucif L, Bakour S, Amiri S, Dekhil M, Rolain JM. Co-occurrence of bla
NDM-1 with bla
OXA-23 or bla
OXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria. J Glob Antimicrob Resist. 2016;6:136–41.
Rafei R, Pailhoriès H, Hamze M, Eveillard M, Mallat H, Dabboussi F, et al. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla
OXA-51-like sequence based typing. BMC Microbiol. 2015;15:11–7.
Article
Google Scholar
Bakour S, Touati A, Bachiri T, Sahli F, Tiouit D, Naim M, et al. First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals. 2014. J Infect Chemother. 2014;20:696–701.
Article
CAS
PubMed
Google Scholar
Pasanen T, Koskela S, Mero S, Tarkka E, Tissari P, Vaara M, et al. Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in hospital district of Helsinki and Uusimaa. Plos One. 2014;9:e85854.
Article
PubMed
PubMed Central
Google Scholar